The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
The Alfred/Monash Centre For Therapeutics And Clinical Research
Funder
National Health and Medical Research Council
Funding Amount
$2,000,000.00
Summary
The Centre will provide a national resource for the evaluation of new and existing drugs. It will focus particularly on investigator-initiated research that is not well served by present funding arrangements. With the cost of pharmaceuticals rising at an annual rate of 15-20 percent there is a clear need for independently developed, comparative information on both new and existing agents. It will also address the virtual absence in Australia of a major academic research focus on drug safety and ....The Centre will provide a national resource for the evaluation of new and existing drugs. It will focus particularly on investigator-initiated research that is not well served by present funding arrangements. With the cost of pharmaceuticals rising at an annual rate of 15-20 percent there is a clear need for independently developed, comparative information on both new and existing agents. It will also address the virtual absence in Australia of a major academic research focus on drug safety and pharmacoeconomics.Read moreRead less
Evaluating The Potential Of HERG Channel Agonists As Mechanistically Targeted Antiarrhythmics
Funder
National Health and Medical Research Council
Funding Amount
$414,786.00
Summary
Abnormal heart rhythms cause ~10 % of deaths in the western world and this number is increasing. To date there has been little success in identifying drugs that are effective in treating these disorders. By studying a rhythm disturbance called long QT syndrome we will examine whether specifically targeting drugs to the molecular building blocks of these arrhythmias is an appropriate route for development of more effective drugs.